PMC:7321036 / 45172-45492
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T365 | 92-100 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
| T366 | 275-279 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T542 | 40-46 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
| T543 | 89-91 | http://purl.obolibrary.org/obo/CLO_0008192 | denotes | NP |
| T544 | 275-285 | http://purl.obolibrary.org/obo/CLO_0000031 | denotes | cell lines |
| T545 | 287-291 | http://purl.obolibrary.org/obo/CLO_0009524 | denotes | Vero |
| T546 | 287-291 | http://purl.obolibrary.org/obo/CLO_0050515 | denotes | Vero |
| T547 | 304-308 | http://purl.obolibrary.org/obo/CLO_0001601 | denotes | A549 |
| T548 | 304-308 | http://purl.obolibrary.org/obo/CLO_0050025 | denotes | A549 |
| T549 | 304-308 | http://purl.obolibrary.org/obo/CLO_0054264 | denotes | A549 |
| T550 | 304-308 | http://purl.obolibrary.org/obo/CLO_0054265 | denotes | A549 |
| T551 | 304-308 | http://purl.obolibrary.org/obo/CLO_0054266 | denotes | A549 |
| T552 | 304-308 | http://purl.obolibrary.org/obo/CLO_0054267 | denotes | A549 |
| T553 | 304-308 | http://purl.obolibrary.org/obo/CLO_0054268 | denotes | A549 |
| T554 | 304-308 | http://purl.obolibrary.org/obo/CLO_0054269 | denotes | A549 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T305 | 15-20 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T306 | 51-60 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T307 | 89-91 | Chemical | denotes | NP | http://purl.obolibrary.org/obo/CHEBI_50803|http://purl.obolibrary.org/obo/CHEBI_53793|http://purl.obolibrary.org/obo/CHEBI_73425 |
| T310 | 213-218 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1006 | 309-313 | Gene | denotes | ACE2 | Gene:59272 |
| 1009 | 144-152 | Disease | denotes | toxicity | MESH:D064420 |
| 1010 | 292-294 | CellLine | denotes | E6 | CVCL:4582 |
| 1011 | 304-308 | CellLine | denotes | A549 | CVCL:0023 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T298 | 0-320 | Sentence | denotes | Here, 68 total drugs and compounds were tested for antiviral efficacy (via qRT-PCR, anti-NP antibody, plaque assay, and/or TCID50) and cellular toxicity at two different institutions (in New York [Mount Sinai, 25 drugs/compounds] and Paris [Institut Pasteur, 62]) and in two cell lines (Vero E6 [68] and A549-ACE2 [61]). |